$FLKS Salarius Pharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Salarius Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Salarius Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Salarius Pharmaceuticals, Inc. for free.
IRS Number: 465087339
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: FLKS
Company Address: 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON 77021
Phone number: 617-874-1821
Former name: Flex Pharma, Inc., date of change: 2014-07-30
Market Capitalization: $76.20M
Prev close: $4.67
Average Daily Volume: 80,760
Days Low: $4.58
Year Low: $3.90
Year High: $13.97
Salarius Pharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2021 | FLKS | Salarius Pharmaceu ... | Rosenblum Mark J | Exec VP Finance, CF ... | Grant | A | 0.57 | 9,563 | 5,422 | 26,286 | 16.7 K to 26.3 K (+57.18 %) |
| Dec 04 2020 | FLKS | Salarius Pharmaceu ... | Burleson Tess | Director | Option Exercise | A | 0.74 | 30,000 | 22,200 | 30,000 | |
| Dec 04 2020 | FLKS | Salarius Pharmaceu ... | Arthur David J. | Chief Executive Off ... | Option Exercise | A | 0.74 | 275,000 | 203,500 | 275,000 | |
| Dec 04 2020 | FLKS | Salarius Pharmaceu ... | McVicar William K. | Director | Option Exercise | A | 0.74 | 30,000 | 22,200 | 30,000 | |
| Dec 04 2020 | FLKS | Salarius Pharmaceu ... | Rosenblum Mark J | Exec VP Finance, CF ... | Option Exercise | A | 0.74 | 80,000 | 59,200 | 80,000 | |
| Dec 04 2020 | FLKS | Salarius Pharmaceu ... | HANISH ARNOLD C | Director | Option Exercise | A | 0.74 | 30,000 | 22,200 | 30,000 | |
| Dec 04 2020 | FLKS | Salarius Pharmaceu ... | Lieber Jonathan I | Director | Option Exercise | A | 0.74 | 30,000 | 22,200 | 30,000 | |
| Dec 04 2020 | FLKS | Salarius Pharmaceu ... | McCreedy Bruce J Jr. | Director | Option Exercise | A | 0.74 | 30,000 | 22,200 | 30,000 | |
| Dec 04 2020 | FLKS | Salarius Pharmaceu ... | Lammers Paul | Director | Option Exercise | A | 0.74 | 30,000 | 22,200 | 30,000 | |
| Nov 05 2020 | FLKS | Salarius Pharmaceu ... | Arthur David J. | Chief Executive Off ... | Grant | A | 0.56 | 4,879 | 2,737 | 86,425 | 81.5 K to 86.4 K (+5.98 %) |
| Nov 05 2020 | FLKS | Salarius Pharmaceu ... | Rosenblum Mark J | Exec VP Finance, CF ... | Grant | A | 0.56 | 4,723 | 2,650 | 16,723 | 12 K to 16.7 K (+39.36 %) |
| Aug 24 2020 | FLKS | Salarius Pharmaceu ... | HANISH ARNOLD C | Director | Buy | P | 0.98 | 4,000 | 3,920 | 11,350 | 7.4 K to 11.4 K (+54.42 %) |
| Aug 20 2020 | FLKS | Salarius Pharmaceu ... | Arthur David J. | Chief Executive Off ... | Buy | P | 1.01 | 1,000 | 1,010 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Aug 20 2020 | FLKS | Salarius Pharmaceu ... | Arthur David J. | Chief Executive Off ... | Buy | P | 1.01 | 1,000 | 1,010 | 1,000 | 0 to 1,000 |
| Aug 18 2020 | FLKS | Salarius Pharmaceu ... | Rosenblum Mark J | Exec VP Finance, CF ... | Buy | P | 1.00 | 5,000 | 5,000 | 12,000 | 7 K to 12 K (+71.43 %) |
View all Salarius Pharmaceuticals, Inc. insider transactions.